Ratish Krishnan is a Senior Strategy Consultant in the Novel Modalities BioProcessing group for the Americas at MilliporeSigma. He is passionate about providing solutions to bring treatments to market. A Process Development Scientist by background, he has over 13 years of experience in vaccine, monoclonal antibodies and viral vector modalities from pre-clinical to late stage process characterization, validation and commercialization activities such as BLA authoring. As a Biochemical engineer, he holds a Master’s degree in biotechnology from the Pennsylvania State University. Ratish has managed process development teams at Novartis and Pfizer prior to his current role where he serves as global subject matter expert for viral vector manufacturing and provides strategic guidance to internal stakeholders and key customers. He is active in his thought leadership activities at scientific conferences, technical webinars and key authorship contributions in peer-reviewed articles and white papers.
